PL1781649T3 - Podstawione hydantoiny - Google Patents

Podstawione hydantoiny

Info

Publication number
PL1781649T3
PL1781649T3 PL05771890T PL05771890T PL1781649T3 PL 1781649 T3 PL1781649 T3 PL 1781649T3 PL 05771890 T PL05771890 T PL 05771890T PL 05771890 T PL05771890 T PL 05771890T PL 1781649 T3 PL1781649 T3 PL 1781649T3
Authority
PL
Poland
Prior art keywords
substituted hydantoins
hydantoins
substituted
Prior art date
Application number
PL05771890T
Other languages
English (en)
Inventor
Xin-Jie Chu
Nader Fotouhi
Nicholas John Silvester Huby
Norman Kong
Lee Apostle Mcdermott
John Anthony Moliterni
Zhuming Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL1781649T3 publication Critical patent/PL1781649T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
PL05771890T 2004-08-17 2005-08-09 Podstawione hydantoiny PL1781649T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60217504P 2004-08-17 2004-08-17
US68299705P 2005-05-20 2005-05-20
PCT/EP2005/008633 WO2006018188A2 (en) 2004-08-17 2005-08-09 Substituted hydantoins
EP05771890A EP1781649B1 (en) 2004-08-17 2005-08-09 Substituted hydantoins

Publications (1)

Publication Number Publication Date
PL1781649T3 true PL1781649T3 (pl) 2009-01-30

Family

ID=35589619

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05771890T PL1781649T3 (pl) 2004-08-17 2005-08-09 Podstawione hydantoiny

Country Status (16)

Country Link
US (1) US7427635B2 (pl)
EP (1) EP1781649B1 (pl)
JP (1) JP4927733B2 (pl)
KR (2) KR20090006885A (pl)
AR (1) AR050297A1 (pl)
AT (1) ATE404556T1 (pl)
AU (1) AU2005274390B2 (pl)
BR (1) BRPI0514515A (pl)
CA (1) CA2576599A1 (pl)
DE (1) DE602005008986D1 (pl)
ES (1) ES2313389T3 (pl)
MX (1) MX2007001846A (pl)
PL (1) PL1781649T3 (pl)
RU (1) RU2383542C2 (pl)
TW (1) TW200621764A (pl)
WO (1) WO2006018188A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200621766A (en) * 2004-09-17 2006-07-01 Hoffmann La Roche Substituted hydantoins
US7612212B2 (en) * 2006-02-22 2009-11-03 Hoffmann-La Roche Inc. Substituted hydantoins
JP2010526848A (ja) * 2007-05-11 2010-08-05 エフ．ホフマン−ラ ロシュ アーゲー 難溶性薬物用の医薬組成物
JP2010536723A (ja) * 2007-08-16 2010-12-02 エフ．ホフマン−ラ ロシュ アーゲー 置換ヒダントイン
US8063085B2 (en) * 2007-12-20 2011-11-22 Hoffmann-La Roche Inc. Substituted hydantoins
KR20110022672A (ko) * 2008-06-16 2011-03-07 유니버시티 오브 테네시 리서치 파운데이션 암 치료용 화합물
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
US9084781B2 (en) 2008-12-10 2015-07-21 Novartis Ag MEK mutations conferring resistance to MEK inhibitors
WO2011000945A2 (en) * 2009-07-03 2011-01-06 Nensius Research A/S Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns
MX340392B (es) 2010-02-25 2016-07-06 Dana Farber Cancer Inst Inc Mutaciones del protooncogen de serina/treonina-proteina cinasa b-raf (braf) que confieren resistencia a los inhibidores del protooncogen de serina/treonina-proteina cinasa b-raf.
EP3064204A1 (en) 2010-03-01 2016-09-07 GTx, Inc. Compounds for treatment of cancer
EA030276B1 (ru) 2010-03-09 2018-07-31 Дана-Фарбер Кэнсер Инститьют, Инк. Способы идентификации страдающих раком пациентов и лечения рака у пациентов, у которых имеется или развивается резистентность к первой терапии рака
WO2011134969A1 (de) 2010-04-28 2011-11-03 Bayer Cropscience Ag Ketoheteroarylpiperidin und -piperazin derivate als fungizide
US20150141470A1 (en) 2012-05-08 2015-05-21 The Broad Institute, Inc. Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy
IL280639B (en) * 2018-09-17 2022-07-01 Yungjin Pharmaceutical Co Ltd History of thiazoles and their pharmaceutically acceptable salts
WO2021182914A1 (ko) * 2020-03-13 2021-09-16 영진약품 주식회사 신규한 cdk7 억제 화합물 및 이의 약제학적으로 허용가능한 염
KR20210116325A (ko) * 2020-03-13 2021-09-27 영진약품 주식회사 티아졸 유도체 또는 이의 약제학적으로 허용가능한 염을 포함하는 암의 예방 또는 치료용 약학 조성물
KR20210146144A (ko) 2020-05-26 2021-12-03 엘지전자 주식회사 카트부

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770573A (en) * 1993-12-06 1998-06-23 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same
ATE277895T1 (de) 1997-07-01 2004-10-15 Warner Lambert Co 4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
CN1209361C (zh) * 2000-05-03 2005-07-06 霍夫曼-拉罗奇有限公司 含乙内酰脲的葡糖激酶激活剂
US20040235919A1 (en) * 2001-07-19 2004-11-25 Paolo Pevarello Phenylacetamido-thiazole derivatives, process for the preparation and their use as antitumor agents

Also Published As

Publication number Publication date
KR20070034635A (ko) 2007-03-28
WO2006018188A2 (en) 2006-02-23
RU2007109651A (ru) 2008-09-27
KR20090006885A (ko) 2009-01-15
US20060041146A1 (en) 2006-02-23
MX2007001846A (es) 2007-03-28
US7427635B2 (en) 2008-09-23
JP4927733B2 (ja) 2012-05-09
WO2006018188A3 (en) 2006-05-18
TW200621764A (en) 2006-07-01
CA2576599A1 (en) 2006-02-23
ATE404556T1 (de) 2008-08-15
BRPI0514515A (pt) 2008-06-10
DE602005008986D1 (de) 2008-09-25
KR100889721B1 (ko) 2009-03-23
AU2005274390A1 (en) 2006-02-23
EP1781649A2 (en) 2007-05-09
AU2005274390B2 (en) 2012-01-19
EP1781649B1 (en) 2008-08-13
RU2383542C2 (ru) 2010-03-10
AR050297A1 (es) 2006-10-11
JP2008509950A (ja) 2008-04-03
ES2313389T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
PL1781649T3 (pl) Podstawione hydantoiny
IL205159A0 (en) Imidazole compounds
EP1717239A4 (en) SUBSTITUTED SYM TRIINDOLE
EP1737831A4 (en) NEUROLOGICALLY ACTIVE COMPOUNDS
ZA200702266B (en) 2-morpholino-4-pyrimidone compound
EP1732560A4 (en) SUBSTITUTED CINNOLINE-4-YLAMINE
IL187279A0 (en) Hydantoin compounds
IL178208A0 (en) Novel imidazoles
GB0415663D0 (en) Compound
EP1755617A4 (en) PERFLUORCARBON-SOLUBLE COMPOUNDS
GB0408771D0 (en) Compound
GB0405193D0 (en) Compounds
IL180888A0 (en) Substituted n-acyl-2-aminothiazoles
GB0421106D0 (en) Compound
GB0405101D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0408772D0 (en) Compounds
GB0425969D0 (en) Compound
GB0411562D0 (en) Compound
ZA200700723B (en) Substituted N-acyl-2-aminothiazoles
GB0428295D0 (en) Compound
GB0403595D0 (en) Compounds
ZA200703075B (en) Imidazole compound
GB0401656D0 (en) Compounds
GB0400696D0 (en) Compounds